Etiometry Brings Advanced Visualization and Analytics to the Hospital Bedside

News and Press Releases

Introduces Persistent Display Feature to Streamline Clinical Workflows in Hospital ICUs

BOSTON, February 23, 2017 – Etiometry, a pioneering leader in next-generation patient monitoring, has introduced Persistent Display functionality that allows hospital care givers to view near real-time patient trend information continuously by the bedside to improve care delivery.

Persistent Display is now bundled into Etiometry T3 Visualization & Data Aggregation Software, an FDA-cleared software application to collect, store, and visualize ICU data in near real-time. It allows patient trend information to be continuously displayed at the bedside—such as on a wall-mounted monitor—to provide physicians and nursing staff with always-on, at-a-glance views into the clinical course of critically ill patients.

The Persistent Display feature is immediately available with T3 Visualization & Data Aggregation Software, and existing customers can implement Persistent Display at no extra costs. According to Etiometry COO Evan Butler, “What is often overlooked today when discussing healthcare predictive analytics is the integration of analytics into the clinical workflow. This feature allows hospitals to improve the integration of analytics into the workflow to enable next-generation patient monitoring.”

Hospitals implementing T3 Visualization & Data Aggregation can now deploy a regular PC and a monitor at the beside to provide aggregated views of patient data with the analytics enabled by Etiometry Risk Analytics Algorithms.

Since Persistent Display mode displays high-resolution, trended device and lab data for an ICU patient, it can be used in several clinical workflows such as during resuscitation, rounds, nursing hand-offs and post-event quality reviews. It also provides easy access to correlated information about an ICU patient to a bedside nurse or clinicians who are evaluating and making clinical decisions on possible interventions.

Persistent Display was co-developed and is utilized by Boston Children’s Hospital in collaboration with Etiometry.About Etiometry

Etiometry Inc. is the leader in clinical decision-support software for the intensive care environment. Our technologies provide valuable clinical insight and analysis to support early recognition of subtle changes in patient condition to avoid complications and speed recovery. Etiometry is committed to improving patient outcomes, increasing clinical efficiency, and lowering costs of care through the more effective use of all available data.

For more information, visit

We’d love to hear from you

Whether you’re curious about how Etiometry can help support your team, the platform’s latest outcomes data or a demo – we’re ready to answer your questions.

Contact Us


Etiometry Awarded Frost & Sullivan’s 2024 North American Enabling TechnologyLeadership Award for Leading Innovation in Clinical Decision Support Systems

Etiometry’s solutions provide healthcare professionals with actionable intelligence, setting new benchmarks in critical care treatment. NEWS RELEASE ORIGINALLY ISSUED BY FROST & SULLIVAN San Antonio, TX — May 21, 2024 —Frost & Sullivan recently researched the clinical decision support for critical care industry and, based on its findings, recognizes Etiometry with the 2024 North American […]

Radiometer and Etiometry Announce Commercial Partnership to Empower Physicians by Optimizing Workflows and Decision Making in High Acuity Care Settings

Acute care diagnostics medical device provider and leading AI-based clinical intelligence company announce commercial partnership BOSTON, Mass. & BREA, Cali. –May 14, 2024- Radiometer, a leading medical device company specializing in acute care testing solutions, and Etiometry, a leader in clinical decision-support software for critical care, today announced a new commercial partnership to enhance clinical […]